NYSEARCA:KURE KraneShares MSCI All China Health Care Index ETF (KURE) Price, Holdings, & News $15.49 +0.30 (+1.97%) As of 04:10 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsOwnershipRatingsBuy This Stock About KraneShares MSCI All China Health Care Index ETF (NYSEARCA:KURE) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get KURE alerts:Sign Up Key Stats Today's Range$15.20▼$15.4950-Day Range$13.39▼$16.0052-Week Range$12.91▼$20.51Volume4,741 shsAverage Volume41,634 shsMarket Capitalization$85.20 millionAssets Under Management$81.96 millionDividend Yield1.16%Net Expense Ratio0.65%Aggregate RatingModerate Buy ETF OverviewThe KraneShares MSCI All China Health Care Index ETF (KURE) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index of large- and mid-cap Chinese stocks in the health care sector. KURE was launched on Feb 1, 2018 and is managed by KraneShares.Read More… KraneShares MSCI All China Health Care Index ETF ExpensesTypeKUREHealth Care ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.78%0.57%0.56%0.51%0.53%Other Expenses0.01%0.30%0.48%0.56%0.52%Total Expense0.79%0.70%0.72%0.73%0.71%Fee Waiver-0.14%-0.45%-0.49%-0.66%-0.54%Net Expense0.65%0.61%0.63%0.58%0.60% Receive KURE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for KraneShares MSCI All China Health Care Index ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address KURE ETF News Headlines3 ETFs Thriving in April’s Market Chaos—Are You Missing Out? (KURE)These ETFs beat the S&P 500 in April 2025’s turbulent market. Learn how TOLZ, VIXY, and KURE can help stabilize your investment strategy.April 15, 2025 | marketbeat.comNew Drivers For China Health Care: AI Med-Tech Innovation, Cancer Treatment, And Favorable Balance Of TradeMarch 18, 2025 | seekingalpha.comThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs China for growth. Nvidia depends on the global chip chain. The MAG 7 have already bled $3.4 trillion — and the next phase could be worse. But while panic sets in, there's a small group of investors pulling in reliable, high-yield monthly income…April 30, 2025 | Investors Alley (Ad)KraneShares Bosera MSCI China A 50 Connect Index ETF (KBA) Dividend HistoryMarch 2, 2025 | nasdaq.comChina Market Update: The Tale Of Two China’s & Their Investors Returns!November 11, 2024 | forbes.comAmundi MSCI World Health Care UCITS ETF EUR Acc (LYXHLTW)October 8, 2024 | investing.comSee More Headlines KURE ETF - Frequently Asked Questions How have KURE shares performed this year? KraneShares MSCI All China Health Care Index ETF's stock was trading at $14.19 at the beginning of the year. Since then, KURE shares have increased by 9.2% and is now trading at $15.49. View the best growth stocks for 2025 here. How do I buy shares of KraneShares MSCI All China Health Care Index ETF? Shares of KURE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of KraneShares MSCI All China Health Care Index ETF own? Based on aggregate information from My MarketBeat watchlists, some other companies that KraneShares MSCI All China Health Care Index ETF investors own include Alibaba Group (BABA), NVIDIA (NVDA), Meta Platforms (META), PayPal (PYPL), Visa (V), Micron Technology (MU) and Tesla (TSLA). Fund Details IssuerKraneShares Fund NameKraneShares MSCI All China Health Care Index ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:KURE Inception Date1/31/2018 Fund ManagerMark Schlarbaum WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkMSCI China All Shares Health Care 10/40 Index CategorySector FocusHealth Care Development LevelEmerging Markets RegionAsia-Pacific Number of Holdings54 Fund Statistics Assets Under Management$81.96 million Average Daily Volume$26,805.00 Discount/Premium-0.13% Administrator, Advisor and Custodian AdministratorSEI Investments Global Funds Services AdvisorKrane Funds Advisors, LLC CustodianBrown Brothers Harriman & Co. DistributorSEI Investments Distribution Co. Transfer AgentBrown Brothers Harriman & Co. TrusteeN/A Lead Market MakerGTS Options OptionableN/A Short Interest7,300 shs Miscellaneous Outstanding Shares5,500,000Beta0.26 Creation Unit50,000 Creation Fee$1,320.00 7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.Get This Free Report Top 10 KURE HoldingsJiangsu Hengrui Medicine Co., Ltd.Holding Weight: 8.36%BeiGene, Ltd.Holding Weight: 7.25%Shenzhen Mindray Bio-Medical Electronics Co., Ltd.Holding Weight: 7.06%WuXi Biologics (Cayman) Inc.Holding Weight: 5.70%Innovent Biologics, Inc.Holding Weight: 4.70%Akeso, Inc.Holding Weight: 4.07%CSPC Pharmaceutical Group LimitedHolding Weight: 3.61%WuXi AppTec Co., Ltd.Holding Weight: 3.53%Zhangzhou Pientzehuang Pharmaceutical., LtdHolding Weight: 3.45%Aier Eye Hospital Group Co., Ltd.Holding Weight: 3.39%Full Holdings DetailsKURE Sector ExposureKURE Industry Exposure This page (NYSEARCA:KURE) was last updated on 4/30/2025 by MarketBeat.com Staff From Our PartnersM.A.G.A. is Finished – This Could be even BetterYou’ve no doubt heard Trump’s rally cry: Make America Great Again. But recently the President made a big ch...Paradigm Press | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredChina’s next move could destroy U.S. techThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredTop performing AI play of the decade…? (The answer will shock you)You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding KraneShares MSCI All China Health Care Index ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share KraneShares MSCI All China Health Care Index ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy KURE Stock Free KURE Stock Alerts